Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Ligence is a Lithuanian medical technology company founded in 2018 and based in Vilnius. Its software automates the analysis of heart ultrasound images. The product is certified for clinical use in Europe.
News
Ligence secures second FDA 510(k) clearance, adding fully automated Left Ventricular Strain analysis
/! elementor - v3.19.0 - 28-02-2024 / .elementor-widget-text-editor.elementor-drop-cap-view-stacked .elementor-drop-cap{background-color:#69727d;color:#fff}.elementor-widget-text-editor.elementor-drop-cap-view-framed .elementor-drop-cap{color:#69727d;bord
Read more
Report
Strengthening Ligence's Export Potential
UAB "Ligence" is excited to announce the launch of our newly funded project, "Strengthening Ligence export potential" (Project code: 02-121-K-0191). This initiative is directed at expanding the export of our artificial intelligence solution, "Ligence Hear
Read more
Report
Ligence Heart receives FDA 510(k) clearance
Lithuania, November 26th, 2025 - Ligence announces that its AI-powered echocardiography software, Ligence Heart, has received U.S. Food and Drug Administration (FDA) 510(k) clearance. Ligence Heart, is an AI-powered software that automates measurements an
Read more
Report
AI successfully automates heart chamber quantification during stress echocardiography
A new study published in the European Heart Journal - Digital Health demonstrates the feasibility of using artificial intelligence for fully automated quantification of heart chambers during pharmacological stress echocardiography.The research validated A
Read more
Report
Ligence study published in Echocardiography (Wiley)
Ligence's latest manuscript has been published in the US-based journal Echocardiography (Wiley). The study evaluated Ligence's AI-powered software for the automated assessment of left ventricular diastolic function. Using data from 302 patients, the resul
Read more
Report
Pro access
Upgrade to see all 12 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.